Nuzenio

Hepatocellular

Hepatocellular news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Diagnostic Performance of AFP, PIVKA-II, and the ASAP Score for Distinguishing Hepatocellular Carcinoma With and Without Portal Vein Tumor Thrombus: A Retrospective Single-Center Study From Pakistan - CureusCureus · Tue, 11 Aug 2026 05:38:44 GMT Johns Hopkins Experts Co-Author New Treatment Framework for Liver Cancer - bioengineer.orgbioengineer.org · Tue, 11 Aug 2026 02:24:51 GMT Liver cancer experts co-author new treatment framework for hepatocellular carcinoma - Medical XpressMedical Xpress · Mon, 10 Aug 2026 17:40:12 GMT Dr Akkus on Making Second-Line HCC Decisions Without Randomized Data - OncLiveOncLive · Mon, 10 Aug 2026 15:56:15 GMT Dr Akkus on the Second-Line Evidence Gap in Advanced HCC - OncLiveOncLive · Fri, 07 Aug 2026 20:20:25 GMT Targeting 4EBP1/HSP90β/Nrf2 Sensitizes β-Catenin-Mutant Liver Cancer to mTOR Inhibitors Through Ferroptosis - bioengineer.orgbioengineer.org · Fri, 07 Aug 2026 16:09:36 GMT Reviewing the EMERALD-1 Trial of TACE With Durvalumab and Bevacizumab - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 13:54:51 GMT Considering STRIDE for Child-Pugh B7 and Other Underrepresented Patients - CancerNetworkCancerNetwork · Fri, 07 Aug 2026 12:09:51 GMT

Timeline

Tue, 11 Aug 2026 05:38:44 GMTDiagnostic Performance of AFP, PIVKA-II, and the ASAP Score for Distinguishing Hepatocellular Carcinoma With and Without Portal Vein Tumor Thrombus: A Retrospective Single-Center Study From Pakistan - Cureus

Tue, 11 Aug 2026 02:24:51 GMTJohns Hopkins Experts Co-Author New Treatment Framework for Liver Cancer - bioengineer.org

Mon, 10 Aug 2026 17:40:12 GMTLiver cancer experts co-author new treatment framework for hepatocellular carcinoma - Medical Xpress

Mon, 10 Aug 2026 15:56:15 GMTDr Akkus on Making Second-Line HCC Decisions Without Randomized Data - OncLive

Fri, 07 Aug 2026 20:20:25 GMTDr Akkus on the Second-Line Evidence Gap in Advanced HCC - OncLive

Fri, 07 Aug 2026 16:09:36 GMTTargeting 4EBP1/HSP90β/Nrf2 Sensitizes β-Catenin-Mutant Liver Cancer to mTOR Inhibitors Through Ferroptosis - bioengineer.org

Related explainers

ElectionsElection stories need careful handling because polls, turnout, legal challenges, and campaign claims can change quickly.HealthHealth stories help readers understand public-health signals, medical research, hospital systems, medicines, disease updates, and safety guidance.HealthcareHealthcare stories can affect personal decisions, so Nuzenio treats them as information that should be checked with original sources and professionals.

Connected entities

Liver Cancer7 live mentions American Journal4 live mentions AFP2 live mentions PIVKA2 live mentions ASAP Score2 live mentions Distinguishing Hepatocellular Carcinoma2 live mentions With2 live mentions Without Portal Vein2 live mentions Tumor Thrombus2 live mentions A Retrospective Single2 live mentions

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Hepatocellular.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.